ClinConnect ClinConnect Logo
Search / Trial NCT06192836

Placental Removal Method And Uterine Massage On Preventing Postpartum Hemorrhage

Launched by BUSRA LEKESIZ · Jan 4, 2024

Trial Information

Current as of November 09, 2025

Not yet recruiting

Keywords

Postpartum Atony Uterine Massage Hemorrhage Placenta Cesarean

ClinConnect Summary

This clinical trial is studying two different methods for removing the placenta during cesarean deliveries to see which one might help prevent excessive bleeding after birth, known as postpartum hemorrhage. Researchers want to compare a technique called manual removal of the placenta with another method called controlled cord traction. They believe that while manual removal might be quicker, it could also lead to more complications, like infections and increased bleeding. Additionally, the trial will explore the effectiveness of uterine massage after cesarean delivery, a technique that has shown benefits in vaginal births but hasn’t been studied much in cesarean cases.

To participate in this trial, women must be at least 18 years old, have a single baby due at 37 weeks or later, and should not have any previous issues with uterine bleeding or other serious health problems, like gestational diabetes. Participants will undergo one of the two placenta removal methods during their cesarean delivery, and the research aims to find out which method leads to better outcomes regarding postpartum bleeding. This study is particularly important for improving maternal health, especially in areas with high rates of complications after childbirth.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Live singleton pregnancy of 37 0/7 weeks or more
  • Without history of previous uterine atony
  • No comorbidities
  • No gestational hypertension or gestational diabetes mellitus
  • Exclusion Criteria:
  • In utero fetal death
  • Multiple gestation
  • History of uterine atony
  • Vaginal birth
  • Previous history of cesarean delivery

About Busra Lekesiz

Busra Lekesiz is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a focus on developing cutting-edge therapies across various therapeutic areas, Busra Lekesiz emphasizes rigorous scientific methodologies and ethical practices in all its trials. The organization collaborates with healthcare professionals, regulatory bodies, and research institutions to ensure the highest standards of safety and efficacy. By fostering an environment of transparency and collaboration, Busra Lekesiz aims to contribute significantly to the field of medicine and enhance the quality of life for patients worldwide.

Locations

Patients applied

0 patients applied

Trial Officials

Busra Lekesiz

Principal Investigator

Ankara Etlik City Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported